Quotient Sciences - Crunchbase Company Profile & Funding

Q: Who invested in Quotient Sciences?

Quotient Sciences is funded by TA Associates.

Q: When was the last funding round for Quotient Sciences?

Quotient Sciences closed its last funding round on obfuscated from a Private Equity round.

Q: How much funding has Quotient Sciences raised to date?

Quotient Sciences has raised obfuscated.

Overview

Quotient Sciences

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Quotient Sciences

CB Rank

178273

Quotient Sciences provides formulation development, clinical pharmacology, clinical & commercial manufacturing services.

Acquired by

Permira

Founded

obfuscation

Private

Private Equity

Nottingham, Nottingham, United Kingdom

251-500

www.quotientsciences.com/

Clinical Trials

Commercial

Consulting

Funding Rounds

Private Equity

OBF

obfuscation

Key People

Emma Wainwright: Director, People and Reward
Paul Ryan: Vice President Business Excellence
Past Role: Arcinova, CFO

Details

Legal Name

Quotient Sciences

Also Known As

Quotient Bioresearch

Operating Status

Active

Company Type

For Profit

About the Company

Quotient Sciences provides formulation development, clinical pharmacology, clinical & commercial manufacturing services.

Phone Number

+44-800-769-3518

Contact Email

info@quotientclinical.com

Predictions & Insights

Growth Insight

See this Growth Insight

Quotient Sciences is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Translational Pharmaceutics® Integrated Drug Development

A drug development approach integrating clinical activities with real-time cGMP manufacturing to accelerate the development process.

Drug Product Development & Manufacturing

Services covering formulation development, clinical trial manufacturing, and commercial drug product manufacturing.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Quotient Sciences	1	obfuscated obfuscation	TA Associates	Private Equity
obfuscated obfuscation	Private Equity Round - Quotient Sciences	1	obfuscated obfuscation	TA Associates	Private Equity
obfuscated obfuscation	Private Equity Round - Quotient Sciences	1	obfuscated obfuscation	TA Associates	Private Equity
obfuscated obfuscation	Private Equity Round - Quotient Sciences	1	obfuscated obfuscation	TA Associates	Private Equity
obfuscated obfuscation	Private Equity Round - Quotient Sciences	1	obfuscated obfuscation	TA Associates	Private Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Quotient Sciences	1	obfuscated obfuscation	TA Associates	Private Equity
obfuscated obfuscation	Private Equity Round - Quotient Sciences	1	obfuscated obfuscation	TA Associates	Private Equity
obfuscated obfuscation	Private Equity Round - Quotient Sciences	1	obfuscated obfuscation	TA Associates	Private Equity
obfuscated obfuscation	Private Equity Round - Quotient Sciences	1	obfuscated obfuscation	TA Associates	Private Equity
obfuscated obfuscation	Private Equity Round - Quotient Sciences	1	obfuscated obfuscation	TA Associates	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
TA Associates	Yes	Private Equity Round - Quotient Sciences	—
TA Associates	Yes	Private Equity Round - Quotient Sciences	—
TA Associates	Yes	Private Equity Round - Quotient Sciences	—
TA Associates	Yes	Private Equity Round - Quotient Sciences	—
TA Associates	Yes	Private Equity Round - Quotient Sciences	—

Investments

Investment Breakdown

Number of Acquisitions

Investment Breakdown

Number of Acquisitions

M&A Details

Quotient Sciences

was bought out by

Permira

obfuscation

Transaction Name

Quotient Sciences acquired by Permira

Acquired by

Permira

Announced Date

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

251-500

Employee Profiles

Board Members and Advisors

Contacts

211

Employee Profiles

Emma Wainwright Director, People and Reward
Paul Ryan Vice President Business Excellence
Roger Kilburn Managing Director and SVP Candidate Development Services
Sarah (Eccleston) Stevens Senior Vice President & Head of Operations, Drug Product Development & LSCOM Manufacturing